stoxline Quote Chart Rank Option Currency Glossary
  
(CBL)
  0 (0%)    09-27 11:12
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-09-26 4:46:32 PM
Short term     
Mid term     
Targets 6-month :  36.8 1-year :  38.17
Resists First :  31.51 Second :  32.68
Pivot price 31.13
Supports First :  29.61 Second :  24.63
MAs MA(5) :  30.09 MA(20) :  31.25
MA(100) :  27.6 MA(250) :  27.83
MACD MACD :  0 Signal :  0.3
%K %D K(14,3) :  11.6 D(3) :  7.5
RSI RSI(14): 46.4
52-week High :  33.53 Low :  21.1
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CBL ] has closed above bottom band by 26.3%. Bollinger Bands are 48.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 30.54 - 30.71 30.71 - 30.87
Low: 29.35 - 29.57 29.57 - 29.78
Close: 29.96 - 30.29 30.29 - 30.59
Company Description

Headline News

Tue, 16 Sep 2025
CBL Properties Reinvesting Over $200 Million of Free Cash Flow into Properties - Nareit

Tue, 16 Sep 2025
CBL & Associates Properties: Evaluating Valuation After New Mayfaire Hotel and Retail Expansions Boost Growth Prospects - Yahoo Finance

Tue, 09 Sep 2025
News | CBL Properties gets into North Carolina hospitality business - CoStar

Wed, 30 Jul 2025
CBL Properties buys Ashland Town Center mall in $179M package deal - Lane Report

Tue, 29 Jul 2025
Exclusive | Mall Owner CBL Snaps Up New Batch of Mid-Tier Properties - The Wall Street Journal

Tue, 29 Jul 2025
FDA clears Caliway’s trial of CBL-514 for localised fat reduction - Clinical Trials Arena

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 31 (M)
Shares Float 19 (M)
Held by Insiders 11.7 (%)
Held by Institutions 79.2 (%)
Shares Short 1,320 (K)
Shares Short P.Month 1,180 (K)
Stock Financials
EPS 2.07
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 9.35
Profit Margin 12.1 %
Operating Margin 26.2 %
Return on Assets (ttm) 3.2 %
Return on Equity (ttm) 22.1 %
Qtrly Rev. Growth 8.6 %
Gross Profit (p.s.) 11.19
Sales Per Share 17.44
EBITDA (p.s.) 9.5
Qtrly Earnings Growth -43 %
Operating Cash Flow 207 (M)
Levered Free Cash Flow 147 (M)
Stock Valuations
PE Ratio 14.56
PEG Ratio 0
Price to Book value 3.23
Price to Sales 1.73
Price to Cash Flow 4.52
Stock Dividends
Dividend 0.44
Forward Dividend 0
Dividend Yield 1.4%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android